📖
Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study.
Chen Z, Jing H, Huang S, Wang M, Mao D, Li L, Lu S, Zhou X, Bi D, Zhang Y, Chen X, Ma Y, Xia Y, Yi J, Hou Y

Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Clin Transl Radiat Oncol.

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study.
Author / Organization Chen Z, Jing H, Huang S, Wang M, Mao D, Li L, Lu S, Zhou X, Bi D, Zhang Y, Chen X, Ma Y, Xia Y, Yi J, Hou Y
Subject & Discipline Clin Transl Radiat Oncol
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-8225
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »